Sort by
Refine Your Search
-
Listed
-
Field
-
funded by UKRI EPSRC and is fixed term for 12 months. You will be contributing to joint UKRI EPSRC – NSF CBET project on sustainable computer networks, with a focus on carbon emissions reduction and
-
research programme at Oxford. Candidates should hold a PhD in biomedical engineering, computer science, medical physics, statistics, or a related field. A strong track record of first-/senior or co-author
-
new phase microscopy hardware to provide real-time feedback on the polymer network during laser processing. About you You should possess (or be near to completion) of a PhD in optical engineering or a
-
for the provision of research support for the ARC project on risk assessment tools in psychiatry, and particularly in child and adolescent psychiatry. About You You will have or be close to completing a PhD/DPhil in
-
process, leading to more resilient development. An important second aim of the project is in working with networks of institutes in central Asia to strengthen capacity, and to develop further efforts in
-
collaboration with Dr Simon Freakley, University of Bath. Applicants should possess a PhD in Chemistry or a related area (or be close to completion), prior to taking up the appointment. They should be experienced
-
The Kelly lab welcomes individuals with diverse career backgrounds – PhD-level scientists in any discipline with expertise in data and programming, or software engineers outside of academia looking to change
-
haematology, supported by world-class facilities, access to deeply phenotyped clinical cohorts, and a strong collaborative network. You will hold a relevant PhD/DPhil, together with relevant knowledge in normal
-
developing characterisations of network models and interactions with methods in statistical machine learning. The post holder provides guidance to junior members of the research group including project
-
, activation, and effector functions in preclinical models of autoimmunity. This research is part of a broader effort to define how inhibitory receptors tune T-cell responses in health and disease, ultimately